Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Abilify Maintena 400mg powder and solvent for prolonged-release suspension for injection vials (Otsuka Pharmaceuticals (U.K.) Ltd) |
| BNF code | 0402020ADBBAAAA |
| Virtual Medicinal Product | Aripiprazole 400mg powder and solvent for prolonged-release suspension for injection vials |
| Name | Abilify Maintena 400mg powder and solvent for prolonged-release suspension for injection vials |
| Abbreviated name | Abilify Maintena 400mg inj vials |
| Date of name applicability | 7 Jan 2016 |
| Previous name | Abilify Maintena 400mg powder and solvent for suspension for injection vials |
| Supplier | Otsuka Pharmaceuticals (U.K.) Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intramuscular |
| Actual Medicinal Product Packs | |
| Abilify Maintena 400mg powder and solvent for prolonged-release suspension for injection vials (Otsuka Pharmaceuticals (U.K.) Ltd) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_11.1.0_20241111000001, imported on 12th November 2024 at 03:53:04.